Kiran Mazumdar-ShawEvery podcast appearance, updated as new ones drop

Welcome to From Code to Culture , a podcast by UnboxingBLR. This is From Code to Culture’s first episode featuring Kiran Mazumdar-Shaw; the visionary founder of Biocon, and a true blue Bengaluru citizen. Discover how she built India’s largest pharma enterprise with a billion-dollar market cap post-license raj, and how India's biotech and IT sectors grew in tandem with her efforts, including the establishment of Syngene International. Kiran shares her journey of formulating recombinant human insulin, revolutionising diabetes treatment in India and beyond. She delves into Bengaluru’s unique spirit, highlighting initiatives like TenderSURE and the vibrant culture, safe environment, and exciting nightlife that attract young innovators to the city. Explore how efforts like the Science Gallery and MAP Museum are shaping the city’s future. Tune in to hear Kiran’s inspiring story of resilience, vision, and community, and discover how Biocon became a global biotech leader, bringing affordable healthcare solutions to the world. This is an episode you don’t want to miss! Check us out on our socials: Instagram: https://www.instagram.com/fromcodetoculture Twitter: https://x.com/codetoculture LinkedIn: https://www.linkedin.com/company/unboxingblr

Welcome to From Code to Culture , a podcast by UnboxingBLR. This is From Code to Culture’s first episode featuring Kiran Mazumdar-Shaw; the visionary founder of Biocon, and a true blue Bengaluru citizen. Discover how she built India’s largest pharma enterprise with a billion-dollar market cap post-license raj, and how India's biotech and IT sectors grew in tandem with her efforts, including the establishment of Syngene International. Kiran shares her journey of formulating recombinant human insulin, revolutionising diabetes treatment in India and beyond. She delves into Bengaluru’s unique spirit, highlighting initiatives like TenderSURE and the vibrant culture, safe environment, and exciting nightlife that attract young innovators to the city. Explore how efforts like the Science Gallery and MAP Museum are shaping the city’s future. Tune in to hear Kiran’s inspiring story of resilience, vision, and community, and discover how Biocon became a global biotech leader, bringing affordable healthcare solutions to the world. This is an episode you don’t want to miss! Check us out on our socials: Instagram: https://www.instagram.com/fromcodetoculture Twitter: https://x.com/codetoculture LinkedIn: https://www.linkedin.com/company/unboxingblr

Kiran Mazumdar-Shaw is Founder and Executive Chairperson at Biocon & Biocon Biologics. Connect with Kiran Mazumdar-Shaw on Linkedin: https://www.linkedin.com/in/kmazumdarshaw/ Key takeaways 1. I think the real opportunity is immuno oncology because the immune system is an amazing system. 2. All of us have to be lifelong learners. 3. Life is about making sure that you follow the science. Life is about understanding what you're doing. You cannot be panicking, you cannot be ad hoc, and you cannot be irrational. 4. Please question, please query. Please find answers. And please be problem solvers. Don't expect everyone to tell you what to do. 5. Mentorship is about sharing knowledge. It's about bouncing ideas of each other, and it's about being inspired. Key Questions 1. How to deal with setbacks? 2. Who can become your Mentor? 3. What are challenges for women leaders in industry? 4. Why should one focus on physical and mental health? Join us every Tuesday at 8:30 pm (IST) Sessions facilitated by Narendra Chirmule, CEO at SymphonyTech Biologics To learn about Biopatrika Industry Mentorship Program Visit our website: https://biopatrika.com/ #Mentorship #entrepreneurship #biotech Credits: Promotion audio by: Preeti Singh Promotion content by: Charu Gupta Managed by Vikramsingh Gujar, Charu Gupta, Suniana Singh and Shruthy Seshadrinathan Editing by: Virender Singh Music: Aditya Sutar (https://www.facebook.com/AdityaFlute/)

Dr. Kiran Mazumdar-Shaw talks to Pavan Srinath on day 1 of the 21 day lock down in India. She talks about the need for the lock down, the need for more focussed testing, the availability of test kits, vaccine development, treatment drugs and the opportunity for the Indian biotech sector to rise to the challenges.